For Big Pharma in China, Innovation is in the Eye of the Beholder

At the recent ChinaBio® Partnership Forum, innovation in drug development was a major theme.  But individual companies seem to have different conceptions of the word "innovation" as it applies to China drug development. For example, to some, it is a relative term; to others, it is a constant anywhere around the globe. BioWorld, the ThomsonReuters newsletter (see site ), presented the various perspectives on innovation expressed by major players at the conference, and the publication gave us permission to reprint their article. More details..